3 (49) 2012

2012 - - - -, , , - .. , - -. , , .. - - , - -,

. , , .

, , , - , 7 9 2012 . , . 15 , 270 600 . , 50 .

, - , - - , , , , , : , , , , .

, : Anti-age medicine , - VITA LONGA.

, : .

!

CMYK 1

3 2012

. , ...,

. . .

. , ..., . . .

..., . . .

... . .

2002

:

, -

, . . - ,

, , ,

.

, 125040, , , 125040, , . , . 8, . 35

.: (495) 742-44-40, . 115, (499) 557-00-91 e-mail: www.asvomed. ru; info@asvomed.ru

, .

77-13601 20 2002 . 16.03.2012. 6084 1/8. 1.

. 10 . . 1000 . 5973. ,

214000, . , . , 16, .: (4812) 59-99-07, 38-28-65, 38-14-53.

. ., ..., . . ., ... . ., ..., . . ., ..., . .., ..., . . ., ... .., ..., . . ., ..., . . ., ..., . . ., ..., . . ., ... . ., ..., . . ., ..., . . ., ..., . . ., ..., . . ., ..., . . ., ..., . . ., ..., . . ., ... . ., ..., . . ., ..., . . ., ..., . . ., ..., . . ., ..., .

. ., ..., . (. ) .., ..., . (, . ), . ., ... . ., ..., -. . ., ..., . . ., ..., -. (. ) . ., ..., . . ., ..., . (. ) . ., ..., . (. ) . ., ..., . (, ) . ., ..., . . ., ..., . (. ) . ., . ., ..., -. . ., ..., . (, . ) . ., ..., . (. ) . ., ..., . (. ) . ., ..., . (. .-) . ., ..., . . ., ..., . . ., ..., . . ., ..., . . ., ..., . . ., ..., . , -. . ., ..., . . ., ..., . (. ) . ., ..., .

3 2012

2 -

CMYK 2

-

615.8

1-2 ..: , , ..., ;1-2 ..: , , ..., - , . 1-2 ..: , , - 1 . .., ,2 ..: , ...1 1 . .., . , 2 - , .

. 1992 - - , , - , - . , . 2009 14,2 12,4 . , 2001 - 98 162 , 2007 158 . 2009 69,2 (- 62,4 ), 15-20 - .

- ( .., .., 2007, 2009; .., 2009), , - - , , , - , .

31 2000 . 1202 - , . .- 21.03.03 . 113 - . 9 2007 . 1351 2025 ., - . 14 2008 170-

. - 21 2008 . -2248- - - - . - 10.06.2009 302 .

- . , -

, , , , -, ( 70% , 80%), - , -, , , , - . .

30- . - - . -, , - . - , , - . - ., .. . , - .

80-90 . - - , . ,

3 2012

3-

CMYK 3

, - , - , - .

- , . - 2-6 , , . - - ( ).

750 , - , .

2 - .

, . . -

- - , - , , (-) , , - , , , - , - , , - .

:1.

.2. -

.3. -

.4. ()

- .

5. - , - .

6. - .

7. , - - .

- . -:

, , .

, - -, -, -, ,

- ,

, - - ,

, -.

- , - ( ),

, - , , , , - .

. , -, , - (, ) . - .. PWC AF. , , , - , , - .

- , -, . , - -, , . , - , - .

-.

- -. 90% - , , 10% , , . - . - - , , , . , 26 -, , . : . : 2 , - 4 15 45 , , , ,

3 2012

4 -

CMYK 4

, . . 24 - 3 11 , 320 806 /. , .

, - , , , - 13 . :

1. .

2. ( ).

3. - ( ).

4. - ( ).

5. - :

5.1. - .. 4-5 - .

5.2. ( ).5.3. .5.4. , , ,

, , ( ).

5.5. - 8-12 .

6. - , , -, .

, - , - , - , , -, - . - . - , .

, , , - 88% , 46 % . -, , , 32% , 5%. , - 60-65% ., - . 12% , -, , - , .

. -

- ,

- - - . -, . , , - - , .

- .

, (-, .), - - . , -. 30-35 , , 2 - , , - , .

. , 2 -

, -, - , , - , . , , , - , . : , , , - . -, , - .

- .

- . , . , . -, , - , : , , , - , . , , , - . , , - 90% 100% 75% , - .

3 2012

5-

CMYK 5

- , ,

. , -

, , - , - ( - ), . -. - 88% , 32% - . - 46% 5% ().

. 90% - , 15% - 6-12 . 82% - 500 /. -, - , . , - , -

, , - .

20 , , . - , , . -. - .

- () - ( 17-28/166 , 14.04.08 ) - .

. , , .

: , , , .Abstract. This article is devoted to the organizing system of health improvement physical culture, its possibilities in

making healthier the population of Russia in rehabilitation of patients. Making healthier, health improvement physical cul-ture, rehabilitation.

Keywords: health, health fitness, rehabilitation treatment, disease.

. E-mail: ovr44@yandex.ru. . E-mail: ckbb@col.ru. . E-mail: makarovamr@mail.ru. . E-mail: doc-ski@mail.ru.

:

1. .. . . ., . , 2002, 590 .2. .. . // . 5, 1988. . 112-114.3. .. ( , , ): 2 1987 ., 1987 33 .4. .. . ., -, 2001. 432 .5. .., .. . , , -

. ., , 2007, - 264 .6. .., ..

// . ., 2009 56 .7. .. . - (-

): . , 1990. 44 .8. .. . . -

. -, 1998. 22.9. .. . . -

. 38. ., , 2007. - 398-409.10. .. . . ., 2009.

5. - 165-173.11. .. . ., 2009. 100 .12. .. // -

. , 1987. 12 .

6

CMYK 6

3 2012

612.015-055.2

..: , ..., ; ..: , - , .

- , . ,

. , - - , [1]. - - [2]. , () - [3, 4], - 14-21 , - .

. 25 - () - (-) Optima 2000 DV (Perkin Elmer, ) - - (-) ELAN-9000 (Perkin Elmer, ), - (. ).

- . - Excel-97 Statistika-6 - [5]. t- |0,5|).

7

CMYK 7

3 2012

. 2 . .., .., .. 1979 . [8]. - () - : Ca, P, K, Na, Zn, Mn, I, Se, Mg, Fe, Cu, Co. 11 , 12

1. - 1621 , - , /

-- -

-

. (n=47)

. (n=18)

. (n=18)

Al 6.15 0.77 7.98 0.81 12.01 1.43*1

As 0.07 0,01 0.13 0.02* 0.09 0.01

Ca 229.13 13.22 306.76 23.01* 443.46 35.62*1

Cd 0.03 0.01 0.04 0.006 0.03 0.01

Co 0.01 0.002 0.01 0.002 0.03 0.01*1

Cr 0.55 0.06 1.11 0.151* 0.67 0.081

Cu 9.18 0.29 8.94 0.563 10.33 0.531

Fe 14.90 1.28 17.32 1.69 45.96 7.94*1, 2

Hg 0.32 0.04 0.06 0.009* 0.41 0.091

I 0.44 0.07 0.43 0.044 0.38 0.04

K 107.51 20.90 480.92 151.83* 69.25 11.271

Mg 23.31 1.53 27.10 2.33 47.13 4.51*1, 2

Mn 0.40 0.05 0.31 0.061 1.06 0.13*1, 2

Na 222.32 36.10 520.97 122.36* 265.13 40.56*

Ni 0.18 0.02 0.38 0.098* 0.40 0.10*

P 133.23 3.73 142.06 7.04 204.71 6.50*1, 2

Pb 0.41 0.06 1.36 0.25* 1.32 0.37*

Se 0.44 0.03 0.51 0.13 0.62 0.05

Si 40.90 7.72 34.58 7.52 75.82 18.31*1, 2

Sn 0.08 0.01 0.13 0.037 0.17 0.02*

Zn 181.02 7.46 188.27 9.812 274.46 31.79*1, 2

: * - . p

8

CMYK 8

3 2012 2.

- ( ,

, , 1979)

(r>|0,5|; p

9

CMYK 9

3 2012

613.6

1 ..: ;1 ..: , ...; 1 ..: ;2 ..: , ...;3 ..: ;1 ..: , ..., .1 , ., 2 , .-, 3 , .-,

. , - , , . - , - , , - , -, .

, , . - , , - . - , - . .

, - - -, - .

. - -, -, - , - - - .

130 : 76% , 24% . 77% 25 54 , 52 % 3 15

(, ) - 3 : 1( -) , , (24 ); 2( ) , -, , , - (53 ); 3 ( ) , , , - - (53 ).

- 3- : 1 - -

; 2 - ; 3 - . 7- 3- :

1. ( 7 10); 2. ( 11 12); 3. ( - 13 ). -

- [1-3].

. -, , - (-: 1. - 50%, 2. - 40% 3. - 10%).

.1.

- (38%). , 75% (.1).

, - - , . - -, , , (-, , ) - .

- - :

10

CMYK 10

3 20121) -

, 2) -

- .

- - : . 1 10 42%, .2 37-70%, .3 51- 96%.

, -: 1- 2- - , 3- 2 , 2- - . , 3- - - .

, , - -, - . - .

- :

1. (67 . 50%); 2. -

(8 . 6%); 3. -

(17 . 13%); 4. -

(24 . 18%); 5. -

(14 . 11%).

, - . , - 10 . , , - 13%, 2,5 - - . , , - - . , - - -, .

.2.

- 1- -, 1- ( -) 2- 3- ( ), . - - - ( 26% 32%). , 3- , , , .

(. 1.), - - (75%) - , (38%). - , - .

. 3. - - .

. 3.

, - - . - , - , - .

- [4-6].

- (.4).

- - .

- , - , . , , , - , . - , ( , ,

11

CMYK 11

3 2012

.). , , , - .

. - :

1. , , - , , - ;

2. - , - ( , -), - -;

3. - , - -;

4. - , , - .

. 4.

:

1. - -: . . . 22.11.2001, 11-1/282-09

2. .., .., .., .. . .: - . 2001. 492. 3. .., .., .., .., ..- -

- . -, // - . . 2004. .44. 3. .269-277

4. .., .., .., .., .. - // . 2006. 5. .77-79.

5. .., .. . : . 2002. 397 .6. Karganov M., Alchinova I., Arkhipova E., Skalny A.V. - Laser Correlation Spectroscopy: Nutritional, Ecological and Toxic Aspects. In: Biophysics.

A.N. Misra ed.- InTech. 2012. -ISBN 978-953-51-0376-9. P.1-16.

. - . - , - (-, , ). , . , - . - .

: , , .Abstract. Any stable fixation of the pathological trace is preceded by processes of dysregulation of the corresponding

functions. The most probable pathological outcomes can be predicted on the basis of the results of polysystemic sanogenetic monitoring by detecting dysregulation in certain systems of the organism (cardiorespiratory, psychomotor, and metabolism systems). Monitoring is carried out using computerized measurement instrumentation and data processing systems, which provides the basis for strict quantitative assessment of the dynamics of risk for the studied populations. The risks assessment goes from the instrument of control to the rank of controlled processes, which is the basis for successful operation of potentially hazardous industries. Device complex and methodological approaches have been tested during screening examination of workers of the nuclear fuel plant.

Keywords: sanogenetic monitoring, functional balance, the factors of production

. E-mail: hippova@gmail.com . E-mail: alchinovairina@yandex.ru . E-mail: mkarganov@mail.ru . E-mail: niipmm@fmbamail.ru . E-mail: intoks@list.ru

12 ,

CMYK 12

3 2012

,

617.3.

1 ..: , , ..., ;1 ..: , , ...;1 ..: , ;2 ..: , ...;3 ..: ;4 ..: , ...1 . .. - , . 2 .., . 3 . . . , . 4 , . .

. - , . , - -, - . , , - , , .

- - , - [1,2]. - - , - , - [3]. , - , - .

, , -. -, - . ,

.

- / .

. - - , - , . - [4]. - ( 29/03041202/5085-03 11 2003 .). - , , - - . [5] - - -, .

- : , , , : , , - .

40 60 . - , - -. , -

13 ,

CMYK 13

3 2012 . - 50, - 25. , , .

2 . 1- - . 20 , .

2- . . - , 0.4 , 2 4 . - 20 .[6].

-:

, ( - ), - ;

, - , ;

( ), - ;

( %)

- ( / );

d - ( - ).

- 3- - :

1 - , - , - . 50% .

2 5 25 % 75 95 %, -, 40% - .

3 - 0 5% 95 100%, . - 10% .

6 , - :

1. 8 - ;

2. 9 11 - ;

3. 11 - .

. -

41 , - 29,17 +- 1,75 .

- (68%) : , - , . , . - - , . (32%) - , .

- (.1) - ( 2,5%).

1. .

- -

.

-

-

-

-

-

-

:

% 2,5 58,5 39 100

-. , , . 39% , - .

, - , - (.2).

2. (%) .

- 95 :

2,4 7,3 36,5 34,2 19,6 100 4,8 14,6 75,8 4,8 0 100 2,4 19, 5 58,5 12,1 7,5 100 0 7,3 4,9 12,1 75,7 100 0 2,4 2,4 19,5 75,7 100d 2,4 4,9 73,3 17 2,4 100

- - . , - 60% , - - [7].

- , -

14 ,

CMYK 14

3 2012 . - - [5]. , , , 75% - 95 . - , , , - . - . - - - , - [8].

- - : - ; - ; . (. 3).

3. .

- -

1 2 3

- -

-

-

57 10 33

-

39 17 44

-

87 13 0

, -

-

90 0 10

, - - (33% ).

- , , -, , . - - . - , 4% - - , 5 - - .

, - - , 87% , 5 (13%) , .

10% , . 90% - , . - - [9]. - [10].

- - , - .

. - , , - - - . - - - -, .

:

1. .., .., .. // . - 1995. - . XXVII, . 3-4. - .45-50.

2. . . .- .- 2002. 472 .3. .. . .- .- 1991.-

458 .4. .. // .- 2006. 2. . 21-24.5. .., .., .. . -

. // .- 2010.- 3 (43).- . 115-119.6. .., .., .. . -3 -

// .- 2003.- 1.- . 86-89.7. .., .., .. . -

.// .- 2011.- .5, 2.- .189-190.8. Kokotilo K.J., Eng J.J., Curt A. Reorganization and Preservation of Motor Control of the Brain in Spinal Cord Injury: A Systematic Review // J

Neurotrauma. - 2009 November. - 26(11).- 21132126.9. Hedel H.J., Dietz V. Rehabilitation of locomotion after spinal cord injury // Restor Neurol Neurosci.- 2010. - 28(1). - .123-34.10. .. -

// .- 2008.- 1.- C.17-18.

15 ,

CMYK 15

3 2012

. - / . - , . , . , - , .

: , , .Abstract. The features of psychomotor coordination and sensorimotor reactivity were examined in patients with spinal

cervical and/or thoracic injury. Decreases of the tested movement speed and the rate of accuracy and the disturbances in function of sensorimotor error correction were found out. In the same patients adequate parameters of attention and senso-rimotor timing responses to visual and auditory stimuli were detected. Thus the revealed adaptive functional reorganization in psychomotor regulation may indemnify for neurological deficits in patients with spinal injury.

Key words: spinal cord injury, psychomotor coordination, sensorimotor reactivity.

. E-mail: v.bogathov@mail.ru

3 2012

16 ,

CMYK 16

,

-

616-05

1 ..: -; 2 ..: ..., .1 6 3 ... , . 2 .. , .

. - () (- , - ). ( , , , - ) [3,8].

-- [3,9]. , - [2,6,7].

- [6], .

, - [5], (), [2,5,8].

- [4,10,12], -. 80- . , - .., - - . - - - [8]. - , .

. 37 , 10 (30,7%) 27 (69,3%) , -, , - [1]. 52,97,5 - 50,97,2 .

, -

2- : [Guelf G.D.,1993] [10] - 11 - - 4- 6 . 0-13 : - , , 14-26 : -, 27-30 : .

(HDRS) [amilton M.,1967] [11] 25-30 . - 21 , 18-21 . -: 0-7 ; 7-16 ; 16 - - .

. 19% (7 ) 46% (17 -) , 35% (13 ) (.1) , , , - ( , , ), - ( , - , ), . - -10, 24 (65%), 30,7% 69,3%. () - 86% (.2).

() (16 / 27 ) 5% (.3) 14% .

. , - -, , , 30 40 . -, , () - , -

3 2012

17,

CMYK 17

, - - [1].

, - - . - ,

. , , , . , - , .

.1

.2

.3

:

1. .. 2000,390 .2. .. : / .. // Consilium medicum. -2000. 2, 7.

.292-2973. .. , // -

. ., 1988. - .100-104. 4. . . . . : .: , 2005. 310 .5. .. . .

. . ... - 20086. .. . - .: -, 1995. - 192 .7. .. / .., .. , .. // .

. ...2003. 8. 17.8. .. - -

. / . . . ... -20109. Burk F, Kurz L , Moller N. J Suicide risk scales do they help to predict suicidal behaviour'' Ear Arch Psychiati Neural Sci 1985. 235-25310. Guelf G. D. Levoluation clinique standardisee en psychiatrie, psychopathologie generale. Depression, anxiete et anxiodepression. 1993. 11. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 1960,23: 56-6212. Ramberg I.L., Wasserman D. Working conditions in psychiatric care of suicidal patients in Sweden. Soc. Psychiatry Epidemiol. 1997; 32: 391 - 397.

. - , . , , - . . , - .

: - , , .Abstract. The article describes the concept of social-stress disorder, the clinical significance of such of its manifestations

as depression. The authors had shown that the scale of Gotland allows you to identify a major depressive episode with comparable with the scale of assessment of the Hamilton depression performance, using less time. That represents one of the possible solutions to urgent diagnostic tasks. The data can be useful for practitioners, in the practice of which there are patients with social - stress-related disorders.

Key words: social-stress disorders, depression, psychometric testing.

. E-mail:corvett75@mail.ru

3 2012

18 ,

CMYK 18

616-05

..:

, .

. , -, , . , : .. , .. , .. , .. , .. . , , , , , [2,4,6,9,11].

, , - , - [1,3,7,8,11,12,13]

- , , , - . , -, . - -, [6,11,12,13,14].

[3,4,5]. - - - , , .

. , .., 1997 [3]. - - - ( ). - . (1 ), (- 2 ) (3 ). - () (-) .

C-01 c Stab Med 2,08, . .

-

() .. . (EPI), .. [10]. 127 - . .

. - . - 3 .

46 , - 36,2 % , . - , (.. ). , - -.

43 (33,9% ) . , -, , - , .

38 (29,9% ). , - , - , -.

- .. - 1.

, , (1 ). -, , - - - .

- . , - . . - - .

- - , - , , - .

3 2012

19,

CMYK 19

(7 ), - - (8 ), - .

5 6 , -

(5 ) - - - (6 ).

- , . - - - 2.

1. ( ..) - (Mm)

() () () - - - 7,60,17 7,40,29 7,80,26 P.H. P.H. P.H. 5,30,39 8,40,25 6,20,26 p

3 2012

20 ,

CMYK 20

- (11,60,17 7,80,5, ), -. (15,8 0,45) (9,60,53), . - .

, (10,40,52) - (9,80,39) , , - .

:1.

- , - .

2. - : ( ) - 36,2% -

, , ; (- ) 33,9% , , - , - , ; (- ) 29,9% -, , , , - .

3. - , : , , , , - , , -, - . , -, - - .

:

1. .. - // .- .: , 1974, 1(9).-.19-21.2. .. .- : , 1908.3. .., .., .., .. // -

, .2.-.: - - , 1997.- .205-211.4. .., .. // -

: . .- ., 2000.-.9.- .13-24.5. .., .., .., C ..

//. , . .. .- : , 2005.- . 88-89.6. .. : . . . .- .: . - , 2010.- 254.7. .., . : - /. . ..- .: , 2011.- 352.8. .. .- .: , 1962.- 532.9. .. .- .: , 1966.-213c.10. c / .....- .: , 2003.-768.11. .. , , .- : , 1963.- 349.12. .. .- .: , 1973.- 426c.13. . /. .- .: , 1982.- 310c.14. . /. .- .: , 1992.- 224c.

. 127 . , . . 3 : - (36,2%), - (33,9%) (29,9%). - () .. . (I). , : , , , - . , -, - , -.

: , , c, , , , .Abstract. This paper describes a study of typological features 127 students of Moscow university of humanities with

different levels of suggestibility. Determining the level of suggestibility was conducted individually, in the ordinary state of consciousness by V.Zvonikov`s technique with stabilometry. By the nature of psychomotor response to the suggestion of all the subjects were divided into 3 groups: high (36.2%), medium (33.9%) and low-inspired persons (29.9%). Studying of typological features of students of the allocated groups was carried out with use of A questionnaire of structure of tempera-ment V. M. Rusalov's (OST) and G. Ayzenk's (EPI) questionnaire. It was found that students with different levels of suggest-ibility have significant differences in expression and structure indicators such as social and object: plasticity, emotion and pace of activity, and also on indicators of adaptability, an extraversion-introversion and a neuroticism. It allowed to establish that high-inspired persons mainly have lines of the sanguine person phlegmatic person, medium-inspired persons of line of the sanguine person, and low-inspired have lines of the melancholiac phlegmatic person.

Keywords: suggestion, suggestibility, stabilometry, temperament, extraversion, introversion, neuroticism.

: . E-mail: m.pakov@mail.ru

3 2012

21,

CMYK 21

-

616.12:615.8

..: , ...; ..: , , ...

.. , .

. - - - - . , - [1,6,7], - , - . , - - , - , [2]. - - - () - -, , , - : , [3,8,4,5].

. - - - (): - I - III 45 70 ( 49 ) () , - 16 45 (54 ). : , 25 - 28 , - (), (24 26 -), - .

, , - - , ; - , (, -, ), 10.

- ( ). - : 1, 6, RP 4, RP 6, Gi 4, Gi 11, E 36, P7, P1, P 2, V 11 - V 15, , , -. - - : , , -, . 10 . 20

10 - . .

- Biospec 250 , 774 5 /.

. - -, , - 86% .

- , , - - . . - 1.

1. () (% - )

, %

- - ( )

39,2 33,4

-

35,7 33,3

21,4 20 10,7 8,4 7,1 6,7 -

14,3 20

(-, )

14,3 13,3

- . - 57% 60 % - . (- ) 42% 45% .

75 % 60 % . , , , - , .

.

3 2012

22 ,

CMYK 22

, , (- ) - 73 % .

- - , , 62 % .

- - , - 57 % , 43 % - .

, - - - - .

, - , -, , : , - , - (. 2).

2. () (% )

, %

- 16 12,5- -

12 12,5

20 19 20 12,5 8 6 (- , - .)

20 12,5

32 31, ( -)

3225

, ( 5 ) - ,

- - - .

- - 60 % 62% - . - 50% 54 % . - 67 % - 50 % - , .

- - . - , 77% . - 63 % .

, , , - - - 60 % 44 % - .

, - - - .

- - - - - .

. , - - -, . , , , - 2-3 .

:

1. .. . - ., 1993.2. .., .., ../ . . 1990, 11 - . 82 - 86.3. .., .., .., .., .. - -

./ 2- : , , 21-23 , 1996, . 1 - . 37.

4. .. / .., .. - , 2008.- 256. 5. // .., . 3 , 2010 20. 6. .., .. , ./ . . ,

... - .., 1996 - . 25 - 26.7. Evans D., Straab J., Ward H. et all. Depression and Anxiety, 1996/1997, 4 - p. 199 - 208 8. Ding-Zong Wu / Clin. Neurol. Neurosurg., 1990, v. 92, 1 - . 13 - 25.

. - .

Biospec BS LD - 774 - 220 774 . . -

3 2012

23,

CMYK 23

. - .

: - , , , .

Abstract. Laseropuncture by infrared laser for correction psycho - emotional disorders of patients with angina pectoris and cardiopsychoneurosis was used in present investigations. Two groups of patients were treated with semiconductors in-frared laser Biospec BS LD - 774 - 220 with wavelength 774 nm. Similar groups of patients with routine medicine treatments were compared. Psychological and psychiatric status was the criteria of efficiency of both kinds of therapies. Data obtained let to recommend this method to get the best results in tre of patients with angina pectoris and cardiopsychoneurosis.

Keywords: psycho-emotional status, ischemic heart disease, neurocirculatory Dystonia, lazeropunktura.

. E-mail: LUM8@yandex.ru . E-mail: 7967905@mail.ru

-

616.8

1 ..: , ...;2 ..: - , ..., . 1 , ., . 2 , .

. - , , - -, , .

- - , - () , . - , - , 85 93% [93,5,13,14,31].

-, -- - - . - , , .

[1,5,6].

. - [7]. - - , , - - - .

- , , - - . [8,9]. - [28]. - , - , - , - . [15].

- , -

3 2012

24 ,

CMYK 24

- . - ( , ). .

, - , , . - - , [3,6,12,17,18]. - , , - , - , - [19,20,21,23,30].

- , - : , - [2,16,22,24,29]. - , , - - . - . - - : , , , .

, - , , - , [26,27].

- 14 2011 , . ( - .., ., ...).

- - , - .

- , - , -, .

, - , - . -, : - 78%, -76,7%, -

-72,5%, -, 55,8%, 25,8%, -25,8%. - ; - 55,8% .

: - 44,2%, - - 35,0%, - 19,2%, 25,8%, 7,5%, - 5,8% [32].

- .

-, - , . - , - -, , , , .

- - 3-4 : - , - - [10,11]. -, . .

- - () , - , - , , , - , - ( , , , , , - ). - .

-, -, : , - , , .

: I : 1 3- ; 15 -

( , , ) ( - , , , );

- - ( - ), - .

3 2012

25,

CMYK 25

II : -

- : - . - .

- .

. , -

.

- -

(n=60) - - - 96,7%, - 60% (n=60) [32].

. - , , - - .

- , , - .

:

1. // / . .. .- .: -, 2004. .16-17.

2. .. - : . . . . , 2008.

3. .. -: . . . . , 2009.

4. .. . .: ,2005. 208 ., ., .64-106.5. ..// 2002. - 2. . 53-54.6. .., .., .., ..

.// . 2007. - 3 .49-54.7. .. // V -

2008 . 2008, . 10-11.8. .. // ,.-1953.60-61.9. .., ..// , .-1928 .24.10. .., .. . .: , 1981. 271 .11. .., .. ,

: 99/224 (1)// - . 2003.-14.-.15-43.

12. .. : . . . . - , 2007.

13. .. . .: ,2003.-96.14. .. -

: . . . . - , 2009.15. .. --

// IV , . 2. .: , 2003. .31.

16. .. ( ): . . . . , 2010.

17. .. : . . . . - , 2006.

18. .. - - : . . . . . --, 2007.

19. . N 113 21 2003 .20. 2003-2010 . 114 21 2003. 21. . - ., 2004. 22. . -

: / .., .., .. . : , 2005. -37 .

23. . 160 . 26.07.2007 .

24. .. : -. . . . ,1997.

25. - ( , ,2000).

26. 8 2010 . N 430 - 19 2009 . N 597 - , .

27. 19 2009 . N 597 " , - ".

28. ( -)/ .. .- . -.-2002. -138.

29. .. : /3-.:. ,2006. 368 .: .

30. ( 18 2006 . N 1760-).

31. .. // V , . .: , 2005..6-7.

32. .. - : -. . . . , 2010.

3 2012

26 ,

CMYK 26

. - . - , . .

: , , , -

Abstract. The article offers information about perinatal risk factors and about the necessity of providing risk-group chil-dren with comprehensive care as soon as possible. In addition to traditional methods of childrens reabilitation with perinatal pathology in policlinics there may be technologies that were developed in Children's Healthcare Centre in Reutov, Moscow Area.

Key words: perinatal risk factors, perinatal destruction of the central nervous system, abilitation, neuropsychic development.

. E-mail: 92477@list.ru . E-mail: rncvmik@inbox.ru

27

CMYK 27

3 2012

616-07

1, 2 ..: -, ;1, 2 ..: -, ...; 3, 4 ..: , ...1 ;2 , . , ;3 ;4 , . ,

. , ( - 20 60% ) [1]. - , - (). 3-5 , -.

- 2002 1 .150 . (23% -), 55% , 45% - . I II 61,4%. .

- 75%, 57%. . 2 , . 13% 8 , 23%, 20%. 20 , 30 , - . 2/3 . 35%, . 56000 , [2].

, - , - , [3, 4]. , , ,

() , - [5]. , - , - [6].

- () , , , , , , - , - . -, , .

- , - . , - , , - -, . - , - . -, , - , , -, - .

- -

28

CMYK 28

3 2012 - , .

. . - - 23 41 . . (n=12) , - , . (n=11) , - (,1984) (). - , , , . . - . - .

. -. - ( 339, ). - 15 K23D 8000 /. - 30 15000 /. /.

- , 1999 . - - (AAS-3, -) Analist 100 ( Perkin Elmer, ) [7, 8]. - /.

- , , - , () [9]. , - . .. [10]. 280 (Specord M-40 Carl Zeiss, Jena).

- - MS Excel 2003 Statistica ( 6.0). - - t- U- -. - - . p

29

CMYK 29

3 2012 -

- : 5,1 (=0,0000), - - 29,8% (=0,035).

- , [5]. ( 2,2 ), , (=0,034), 45,3%, - - (=0,004).(.1.) - - 42,5% (=0,001), 17% (=0,05).

, -, - : 21% (=0,05), 198% (=0,019). - - . - (. 2.). (R = 0,900; =0,037) (R = - 0,975; =0,005), - (R = - 0,900; =0,037), , , - .

, Fe , (R = 0,900; =0,037). Fe - , (R = - 0,900; =0,037). - Mn , Mn (R = 0,900; =0,037) Mg , Mg - (R = 0,900; =0,037).

- , , .

2. ( )

R (Spearman) p-level

Zn Isoleucine 0,900000 0,037

Fe Serine 0,900000 0,037

Mg Alanine 0,900000 0,037

Fe Phenylalanine 0,900000 0,037

Fe Tryptophan 0,900000 0,037

Mn Ornithine 0,900000 0,037

Mn Histidine 0,900000 0,037

Mg Arginine 0,900000 0,037

Cd Lysine 0,894427 0,041

Cd Tyrosine -0,894427 0,041

u Glycine -0,900000 0,037

Zn Serine -0,900000 0,037

Fe Proline -0,900000 0,037

Fe Cysteine -0,900000 0,037

2. ( )

R (Spearman) p-level

Zn Isoleucine 0,900000 0,037

Fe Serine 0,900000 0,037

Mg Alanine 0,900000 0,037

Fe Phenylalanine 0,900000 0,037

Fe Tryptophan 0,900000 0,037

Mn Ornithine 0,900000 0,037

Mn Histidine 0,900000 0,037

Mg Arginine 0,900000 0,037

Cd Lysine 0,894427 0,041

Cd Tyrosine -0,894427 0,041

u Glycine -0,900000 0,037

Zn Serine -0,900000 0,037

Fe Proline -0,900000 0,037

Fe Cysteine -0,900000 0,037

Fe Leucine -0,900000 0,037

Phenilalanine -0,900000 0,037

Tryptophan -0,900000 0,037

Zn Asparagine -0,974679 0,005

:

1 .., .. - .: - - 2006. 104 .2. .., .. .: - 2006 - 99 .3. .., .., .. . (). .: -

2009 - 69 .4. .., .., .. -

. .: - 1997. 5. .. . . .

. . . 1993.6. .., .., ..

. // 2003. - .389. 5. .714 717.7. .., .., .. - . .: - 1996. 319 .8. ., ., . - . .: - 2008. 543.9. ..

- : . ..... , 2001.10. .., .., .., .., ..

// -1981. . LIX -10. .38-42.11. .. .. //. . .

. . . 2004 - 90 (8). - . 454 455.

30

CMYK 30

3 2012

. - . 20 60% . , - .

- c . . , , - . - - .

: , , .

Abstract. Diagnostics and treating lactic gland diseases is presently an urgent problem. Mammary gland benign tumor is a widespread disease. 20 to 60% women have various forms of mastopathy. Mastopathy is the background for the possible development of mammary gland cancer. We estimated the contents of macro- and microelements and amino acids in the blood serum of somatically healthy women and cases of various mastopathy forms. All diagnoses were histologically sup-ported. In cases of mammary gland phybroadenoma the levels of Zn and Ca, Fe and Mn were significantly higher in the blood serum an evidence of a possible role of these essential microelements in the mastopathy development (p

31

CMYK 31

3 2012

617.57

1 ..: , ..., ;2 ..: , ..., ;3 ..: , ...; 2 ..: , ... 13 . . . 2 2 3 . . . , . 3 , .

. , - , , [6,7,10]. () - - [1,2,5,7,8,11]. - - , - .

, - [3,4,9]. , - - - , . - - -, , .

. - - .

. - 40 ( - 4711.7 , 17411,5 , 74,87,3 ). - : . 20 . , - , , 12 , , - - , .

- (). - - . - , -, -, 15, , - , , , .

, , (). - . - , - - , . , - [1,2]. - - - (-). , - : , , -, - . , - -, . - - CMS (Kuntovaline) (). - . , 4 - (, , , ) - .

32

CMYK 32

3 2012 : 1) - 15 ( , ); 2) - 30 ; 3) - 10 ; 4) - 5 .

- . - , 40% , - 50%, - 60%.

- -. 11 30 - (1 2 ). 120 5 , 30 (1 2 ). 130 . 140 - (30 ) (30 ), (20 ) (20 ) - 1 2 . ( 30 -) 150.

. - . - - 11 (55% ), 10 (50% ). - 9 (45% ), 10 (50% ).

- . 19 (95% ) 18 (90% -) - - . , - - . - , - . , - - , - ( , , ..), - [8,9,10,11].

- ( -) 12 - (60%) 10 (50%) - ; - - 13 (65%) 15 (75%); - 5 (25%) - 3 (15%) - .

- - , - [6,7].

- . - 20% (4 .), - 5% (1 .). - 15% (3 .), - 5% (1 .).

, , 25% (5 .) , 5% (1 .) . - , - 25% (5 .), 15% (3 .), 20% (4 .), - 5% (1 .), 5% (1 .), 5% (1 .).

: - 30% (6 .), - 25% (5 .), , - 35% (7 .), - 25% (5 .), - - 25% (5 .). , - .

, - - - . - , - . - - .

1. .., .., .. - // XXI .: , 2006. 132-133 .

2. .. - - / . . . . , 2006. 47 .

3. .. // .-. . - 1991. - 8. .37-38.4. .., .., .., . .: -, 2009. 188 .5. .., .., .., . -

: (.) , 01.2006 10502, . 02.0006 06262. - ., 2006.-51 .

6. .., .., .. - . - -: , 2006. - 326 .7. .. . : ., 2007. - 2788. .., .., .. -

// VI - - . .: 2004. 316 .

9. Howard S., Hopwood M. Posttraumatic stress disorder. A brief overview//Aust. Fain. Physitian. - 2003. - Vol.32, 9. - P. 683-687.10. Lewit K. Manipulative therapy in Rehabilitation of the locomotor system.- Butterworth., Heinemann 1999.11. Travell Janet G., Simons Lois S. Myofascial pain and dysfunction. The trigger point manual. The lower extremities. Williams and Wilkins, 1992.

33

CMYK 33

3 2012 . -

40 - 1,5 2 . - . 20%, - 5%. - : 30%, - 25%, , - 35%, -.

: , , , -.

Abstract. This article discusses the effectiveness of methods for biomechanical correction inthe rehabilitative treatment of vertebral complications in up to 40 wounded soldiers from combat injuries of the upper extremities at a late stage of the hospital in timefrom 1.5 to 2 years after injury. The main pathological changes were localized zone of cardiothoracic junction and thoracic spine. As a result, the overall treatment ofthe mobility of the spine in the sagittal plane in the intervention group increased by 20%, and in control - at 5%. Maximum isometric muscle strength increased in the intervention group: lumbar flexors at 30%, lumbar extensors - 25%, muscles, spinerotation absorbing - 35% of the wounded in the control - to change the dynamic parameters have been identified.

Keywords: combat trauma of the upper extremity, biomehanoterapiya, low back pain, medical rehabilitation.

. .: 8(495)455-88-13.

616.728.2-002-036.868

1-2 ..: , ;1 ..: , ..., .1 , . , 2 , . ,

. () - [1,2]. , , , [3].

, , - (). - . , - () - () [4,5].

. - 99 (83 16 ) 42 63 - , 2 , 1-2, - . () 3 . 1 (33 ) () -

- , , , . 2 (33 ) , 10 . 3 (33 ) , , - 10 , 8 . - , 14 6 . : 1. . 2. - . 3. . 4. - (, - -) Womac Western Ontario and McMAster Universities Osteorthritis Index ( - - , ) [6], 6 [7]. 5. ( ) (- .., .. [8]. 6. - ( ) .. [9] MFI-20 (Multidinensional Fatigue Inventory [10]. .. , -

34

CMYK 34

3 2012, , , , MFI-20 , , [11].

- Statistica 6,0 Windows - , , t . - m, M , m . p

35

CMYK 35

3 2012 :

1. , . ., , . . - UGUL // . - 2004. - N4. - . 37-42

2. .. . : // -: - .-.:, 2006. -4.-.57-62

3. .., .. : , , , //.- , , 2005.-223 .4. .. . , . 2006; 1:

3-12.5. .., : , -2- ., . . - .: , 2001.-592.6. Bellamy N., Buchanan W.W., Goldsmith C.H. et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient

relevant outcomes to ant rheumatic drug therapy in patients with osteoarthritis of the nip or knee/J.Rheumatol. 1998.-15.- P. 1833-1840.7. Enright PL, Sherill DL. Reference equations for the sixminute walk in healthy adults. Am J Respir Crit Care Med 1998; 158: 1384 1387.8. .., .. , . . :

; 2002: 439.9. .. : . . . . ; 2000: 20.10. Smets E.M., Garssen B., Bonke B., De Haes J.C. The Multidimensional Fatigue Inventory (MFI) psychometric c qualities of an instrument to asses

fatigue. J Psychocom Res 1995; 39 (3): 315-2511. Lobzin V. S. Taxonomy and differentiation of asthenic conditions. Jurn. neur. and psychiatry 1989, 11, p.7 11

. 99 , , - . - , , , - , .

: , , , .Abstract. At 99 patients with osteoarthritis of coxofemoral joints the efficiency of such methods of regenerative medicine,

as physiotherapy exercises in the form of group and individual employment, hydrocinesiatrics and universal gymnastic installation of the Leningrad type was investigated. Essential reduction of expressiveness of a painful syndrome, functional infringements, an adynamy, alarm and depression against the complex therapy including hydrocinesiatrics and universal gymnastic installation of the Leningrad type was established.

Keywords: coxofemoral joints, treatment, physical rehabilitation, physiotherapy exercises.

. E-mail: Svetlana-lfk@mail.ru . E-mail: p_a_chizhov@rambler.ru

-

616.1+616.71

1 ..: , ...;1 ..: , ...;1 ..: , ..., ;1 ..: , ...;2 ..: , ... 1 - , . ;2 - , . .. , .

. - . - ,

, , , - .

- - ,

36

CMYK 36

3 2012 - - [1,2,3]. - () - , - , - [1,2]. 3 , - 7 [3]. , - - ( ) [4]. - - , - [5]. - -, , [4,5]. - - [6]. () , - , , , 30,8% [5]. - , - - [6].

, - , [3,7]. -, - , , ( ) [6]. , , - , . - () - ( ), ( ), [3].

- 93298 , (), - () , , SCORE (Systematic ronary Risk Evaluation) [4]. - () 10 ( ), .. - - 60- . , , - - . : PROCAM, Framingem ..[8,9], , () , , , - (), (),

[4].

, - FRAX (Fracture Risk Assessment Tool), - http: //www.shef.ac.uk/ FRAX [10]. - FRAX - , , . - : , , , , , , , , - , .

, -. , - , . - -, SCORE FRAX , .

: - - - 10 .

. 87 - -, 10 . - , - - .

- - (): 50 (1- ) 37 (2- ) - . 1 - .

1- 2- - (51,95,6 , 53,53,5 , , 43,112,7 ).

1- - , (1- - ) 13,15,6 (1- - ). 2- 11,44,1 .

14 . .. - 1 , - . ... - -. , ().

Hitech 911E (). () / - ,

37

CMYK 37

3 2012 -. - - , . - / - - .

- - () () (SD) Lunar prodigy ( Lunar ) Scaner ID: DF -13113, Spina Phantom ID:11897.

(one mineral density BD, /2) - :

- (BMD L2-4),

- (BMD Neck),-

(BMD Total). - -

- 2009 [4], - 2010 [8], - - - SCORE .

SCORE - - () 10 -: , (), () , .

( - , ) - [8]. : , - 10- , - . 10 : , (), , ( ) , , .

:- 10% (

5%),- 10-20%,- 20%. FRAX (Frac-

ture Risk Assessment Tool) (http: //www.shef.ac.uk/ FRAX) - , - (, ) - 10- [10]. FRAX (/2).

- STATISTICA 5.0 (StatSoft Inc, ). - . - t- - 0,05.

. SCORE . 1- , , : ( ) - ( 13,15,6 ). 2- ( ) - 11,44,1 .

6- - 1- 6- 2- () 1-2 , - 2- - ( ) . - Score. , 1 44 , 2 ( ) 31 . 1.

1. 10- (n, % )

10-

1

2- (n=31)

- (n=50)

-

- (n=44)

3-4 %, Score 3 - - 1 ( 3,2%)

2 %, Score 2 - 3 ( 6,8%) 5 (16,1%)**

1 %, Score 1 12 (24%) 24 (54,5%) 22 (71,0%)**

< 1%, Score 0 38 (76%) 17 (38,6%) 3 ( 9,7%)**

0,250,43 1,082,12* 1,620,75

: (p< 0,05) : * - 1- , ** - 1- 2

, -, - ( : 1- 39,4+3,7 ), . 10- , . - 1- 76% 1- 10

38

CMYK 38

3 2012 - - (.. ).

( - ) - , , , . 2.

2. , - ( ) (n, % )

10-

1

2- - (n=31)

- (n=50)

-

- (n=44)

20 % () - - -10-20% () - 1 ( 2,3%) 2 (6,4%)

5-10% () 2 (4%) 10 (22,7%) 19 (61,4%)*

< 5% () 48 (96%) 33 (75,0%) 10 (32,2%)*

5,1 0,47 6,081,32 7,651,84

: (p< 0,05) : * - 1- 2

- , - SCORE, . , 1- , (< 5%), 96% 75%; ( 5 10%), , - 2% 22,7%.

- 2 ( - ): 6,4% 2,3% - 1- , : 61,4% 2- 22,7% 1- ( - ).

( 20%) .

FRAX FRAX -

10 : , , -, , , , -, , , ( , /2) . 1- -, 2- ( - ). 1- , , FRAX . , - , - , , - ( , ). 3.

3. - 10- - FRAX (n, % )

10- -

1 - - (n=50)

-2- - (n=37)

40 % (Super high) - - 2 ( 5,4%)30-40 (High) 3 (6%) - 17 (45,9%)

20-30% (Moderate) 6 (12%) - 14 (37,8%)

10-20% (Modest) 10 (20%) - 2 ( 5,4%)

< 10% (Low) 31 (62%) - -

9,3 1,42 - 30,622,04

: Super high- , High-, Moderate-, Modest-, Low-.

- - < 10% (62%).

2- - 10 - () - .

2- 2- , , . 1 - - , 50 , 8 - - . - , - 51 , 7 .

2 2 -, 5,4% , 1- .

-

- - . , - 1- ( ) 2- - , . , SCORE, - , FRAX.

1- - - FRAX.

, - 1- ( ) 2 2- . 4 5 - .

4. - 1 (n=50)

FRAX40 % - Super high 0 0 0 030-40% - High 3 - 6 % 0 0 020-30% - Moderate 6 12 % 0 0 010-20% - Modest 10 20 % 0 0 0< 10% - Low 19 38 % 12 24 % 0 0

39

CMYK 39

3 2012 1- ( -

) Low FRAX - Score 0 38% ;

- : 24% - Low FRAX - Score 0 24%,

- : 12% Moderate FRAX - Score 0.

5. - 2 (n=37)

FRAX

40 % - Super high 0 2 - 5,4 % 0 030-40% - High 1 - 2,7 % 11 - 29,7 % 4 - 10,8 % 1 - 2,7 %

20-30% - Moderate 2 - 5,4 % 12 - 32,4 % 2 - 5,4 % 0

10-20% - Modest 0 1 - 2,7 % 1 - 2,7 % 0< 10% - Low 0 0 0 0

40

CMYK 40

3 2012 . - .

- - . , - 1 ( Score 1 24% 54,5%), - , - 2- (71% Score 1). Score 2 2 (16,1% 6,8% 1- ).

- , - . SCORE - .

10 [7,10]. - - ( ) [10].

- , 10- [16].

, - , 10 [7]. 2 .

- , -, , -, . , - , . - [17].

- 1- () 2- - FRAX, , < 10% (62%); 2- ( ), , - .

- , . - - . , - (, ). , , - [17].

, - , - -, - - .

. - : , - , - . , , .

1. .., .. .- .. 2005. .1. 416 . 2. Camm A.J., Luscher T.F., Serruys P.W. Cardiovascular medicine. European Society of Cardiology.- 2006. Blackwell Publishing.- Ch.9. 1122 p.3. .. . - .. .- 2003. 1. 523.4. .. . - .-. 2009.

- 33.5. .., .., .. .// . - 3. -

2007. - .27-30. 6. .. , - . - -

. . .- 2006.- 10. 847.7. .. . , , . .- .-. - 2009. 2. - 270.8. .. .

. ., 2010.9. ., ., . . . .Thompson Reuters.

2011. 1. 130.10. .. .//

. - 2010.- 1. - .6-12.11. .., .., .. . - - : -

. Consilium medicum 2008; 10(6): 419.12. .., .., .. -

- .// -. 2011. - 5. .27-29.

13. .., .. - .// . 2007. - 3. .20-22.

14. Rivera CM, Grossardt BR, Rhodes DJ et al. Increased cardiovascular mortality after early bilateral oophorectomy. // Menopause. 2009; 16(1):15-23.

15. .., .., .. . . - . . 2003. - 15.16. .. - , .// -

. IV . - -,26-29 2010.- .66.17. .. .// . - 2009. - 12. 6. - .14-20.

41

CMYK 41

3 2012

. . ( ), , - . (). - () 87 , 50 , ( 10 ) 37 , . (). - - SCORE, FRAX. - .

: , , - , , SCORE, FRAX.

Abstract. The assessment of total risk is a necessary component in individual prevention and should be considered when developing recommendations in preventive cardiology and in practice of a physician. Its especially in a small cohort of the patients with surgical menopause, using or not hormone replacement therapy (HRT), and having similar characteris-tics on major factors, influencing to the remote f cardiovascular diseases (CVD) and osteoporotic fractures. When surgi-cal menopause occurs in reproductive-age women, HRT is a basic means of correcting their lost function. To specify the cardiovascular system and bone mineral density (BMD) in relation to the use of HRT, examination were made in 87 women with surgical menopause, it has included 50 women, receiving HRT (this group was study during more then 10-years period) and 37 women without HRT. Research of level of BMD was carried out by means of a dichromatic x-ray absorptionmetry (DXA). Total risk cardiovascular mortality was accounted with a help of special tables: Systematic ronary Risk Evaluation (SCORE); and risk of osteoporotic fractures was accounted with a help of a computer program: Fracture Risk Assessment Tool (FRAX). A summary total risk depended on HRT use or non-use.

Key words: surgical menopause, osteoporosis, cardiovascular diseases, hormone replacement therapy, SCORE, FRAX.

:

. E-mail: tatiana-mitrokhina@ yandex.ru

611.83

..: , ...; ..: , ...; ..: ; ..: , ...; ..: , ...

, .

. - , . [1, 2, 3]. - , -, - - [4].

.

- - , - .

. - - 44 (24

42

CMYK 42

3 2012 20 ) 27 59 ( 42,5 [37;49]) - . - S1 20 (45,4%) , L5 - 10 (22,7%/), - L5, S1 . , , - , -, . 1 10 , 8 . 72,6% (32) , . - - , - .

- ( 0 4 ) - - (. , - , , -, ). () 36 , 29,56,3. - - () 7,42,02 . - - - (r=0,12, p>0,05), [5,6].

- () () 01 ( , ) [7]. : - () (), - : () (ALF) , - , () (AHF), (ACF). (): / 100% (): / 100%, .

- Born G. (1962) .. (1980) OBrein J. R. (1963) Chronolog coporation ().

- Statistica 6.1 (StatSoft, Inc., ). . , , (M) - - (s) M(s). , , ( 5) (Me) (, Q1, , Q3) Me [Q1; Q3]. - -. - - - . - ( )

, - . -

43

CMYK 43

3 2012

: 73% - - (), 20% - (), 7% - -. , - , , , , - () - (ALF/ 100%) (0,05) , 2, - - . - .

- - AF/ 100%, .

, - . - , , .

- , - (p

44

CMYK 44

3 20124. .., .., .., .. -

. // . ... - 2008. 2. - C. 15-19 5. .., .., .., .., .. -

. // .-.: . 2006. 168 .6. .., .., .. -

// . 2011. - 5. .34-367. .., .., .. . . // . - 2002;

7 - .3640.8. .., .., .. : -

// , . 2010. 2. .11-129. .. - .//

URL: http://www.medline.by ( 2012-04-04)

. - .

. , - 75% - . , - .

: , , , , , .

Abstract. Study investigates the role of microcirculatory disorders in discogenic radiculopathies and in view of the development of an integrated treatment with physical factors.Were subjected to analysis of treatment outcomes in patients. Revealed that, according to laser doppler flowmetry, microcirculatory disorders in 75% of the cases presented atonic-stagnant type of microcirculation. Developed complexes physiobalneotherapy provided corrective effect on the microcirculation changes as reflected in the improvement of klinichskih manifestations.

Key words: discogenic radiculopathy, a herniated lumbar disc, microcirculation, laser doppler flowmetry, cryomassage, preformed physical factors.

. E-mail: sichi.24@mail.ru

616.65

1 ..: , ..., ;2 ..: -;3 ..: ;3 ..: - 1 , . 2 2, . 3 -, .

. - - [1]. .. . (2000), .. . (2004) - () - 28,2 % 100% [3,4]. , - , -

, , [5]. , , - , - [6]. - (), -

45

CMYK 45

3 2012

:t t t -

t , t

9 9 (,

)

9 -

. ,. , . 15./: (343) 267-38-17mcdens@denascorp.ru

. . . 14/1.: (495) 617-18-66denas_m@mail.ru

tt t t

t t

tttt

tt

46

CMYK 46

3 2012 [7]. . . . (2003) , - [8]. - , - [9].

. - . , , - -.

. - . 96 20 45 ( 34,53,7 ) : - ( 3, 3; NIH, 1995) [10]. - 6 - ( , ). , (, , , , , , - .). - , -, ( 2 , , , , - ).

-. 1. - (). 2. - (IPSS). 3. QoL. 4. (NIH-CPSI) [11]. 5. -01. 6. - Urodyn 1000, Medtronic (-). 7. () - Logic-400 () , , . 8. - ( ). 9. - - Abbott Architect 2000 ().

20 , : - ( 1 ), (- 2 . ), ( 500 , 10 ), ( 1 . ), - ( 500 ).

- . 1 , - 32 , -. 2- -, 32 , , - -. , - , , , -

- . 3- , - 32 , - .

2,6 , - ( ) 4,9 ( , - ) [9]. 77 ( , -, ; -, , ) [12]. - ( , ) 25-75 . - 5 , 10 , - 20 . - - : V-26, V-10, R-2, VC-2, V-23 77 10, 2 , - 40 .

SPSS 15.0. - , -. - () (m). t- -. , , - . - 0,05.

. 20- 86,5% , - , , - 23,6% (p

47

CMYK 47

3 2012 -

: 17%, 31,3% . , 46,7% - 16,2 1,3 . : 16%, 25% , 50% .

, - , , - .. .. (2002). 63,0% - 2,0 ( 1,80,2 3,60,4 , p

48

CMYK 48

3 2012

, - : 27% ( 3,81 0,03 . 4,910,03 .., p

49

CMYK 49

3 2012 . , , .

: , , .

Abstract. The parameters of sexual activity have been studied in 96 patients suffering from a chronic abacterial prostatitis with erectile dysfunction. The patients have been divided into 3 groups. In the main group the medical complex has been added by dynamic electroneurostimulation (DENS), the placebo-influence was spent in the comparison group, and the control group received standard drug therapy.

Expressiveness of chronic prostatitis symptoms and the results of treatment were estimated with NIH-CPSI (S), IPSS (S), IPSS (QoL) questionnaires, index of erectile function assessment, laboratory researches and dopplerography of penile vessels.

DENS has led to 23,6 % improvement of erection quality and to reduction of reactive uneasiness. The parameters received in the main group reliably differed from the data in placebo and control groups.

Keywords: erectile dysfunction, dynamic electroneurostimulation, parameters of sexual activity.

. E-mail: Doctorvik@yandex.ru .. E-mail: Natali7775@mail.ru .. E-mail: vlasov@denascorp.ru

-

615.847 616.8

.: - , ..., ; ..: - , ...; ..: .

, . ,

. , - , -, - . -, , , - - , , , , - , , [13].

- - , - -, - . -

- - - . - , , , - - [4].

, - - -, .. -. - ,

50

CMYK 50

3 2012 - - - . - , - , - .

, - , , - , - - .

- . -, - -, , [3].

, - - [7].

- - - , [8].

- - . , - , , -, , - , . - - , , , - [6].

- , - - - .

- - - . , - , - [2]. - 60-70 % [11]. 86% [12]. 3 - .

- -. , . -, - . - . , , .

, - - , - - [1]. - - , [10].

- - 1 12 [5].

, , , . - , , , - . - , .

-, - . - , , - [9].

, - - - . - - , - - - .

- - - - .

: - 40 - 1 1,5 . 30 , - - (), 10 ( -). -:

51

CMYK 51

3 2012 , , -. 43 , 43 , , 10 .

- - - (35%), (17,5%), - (32,5%), I II (32, 5%), 32-36 (40%).

45% , 22,5% - , . - 17,5% 1800, - 2500 .

-: - 100% , 40 % , 37,5%, - () 37,5%, 87,5%, - - 32,5 % (.1).

1. -

(n=30)

%

-

100

( - )

37, 5

40

- -

87,5

- -

32,5

37,5

100%, - 85%, , , - 87,5%, - 37,5 % . - - 100% , 1-2 , - . 37,5% - , , - , .

- , -, - .

- : - 30% , - - 32, 5 % (.2).

- .

- ( /,

/, /, ). - - -.

2. -

(n=30) %

30

-

32,5

: - . , 45% -, 55% - 10 , - ; 2 - , .

55% , 70% - 5 - - , - - .

- , ( , , -, ). 70% , - . - (60%).

- 90% - , 80% - - , 96,7% - , - , - - .

2-3 - ; 76,6% - ( -, ), - .

, - 3-5 , , - . II .

, , - . 23,3% - , 1 I 4(40%) II . 53, 3% , , - 2 .

,

52

CMYK 52

3 2012 - 1 . 1 II .

, -, - .

- , - - ( 90.0%), (70%),

53

CMYK 53

3 2012

-

612-017.1

1 ..: , ..., ..., ; 2 ..: , ...; 2 ..: , ...; 2 ..: .1 , . 2 - , .

. , - , , [1,2,3], - . , , - , - [4-7]. - , -, , , , , [5-7]. , - , .. .

- , - (), - [8-10], - [9-13]. - , () - , , - ..

- , -.

. - Balb/c, 8 (40 ), . 3- (- 4 Life Research Co.), , , - 1 (1 200 50 ).

- , , , , [15], [1,13] . : , 80 -; ; - ; - - , -, -; ( ) , 1,065; () (-6000) - , .. . - - ; -, - [5-7].

() 12 55-73 , 300 5 - 6 . - [16], [17], (, ) : -, , , , -, , , , -, , [18].

: (), - (m), , ().

54

CMYK 54

3 2012 . -

1. , ,

, - . , - , - , () - . , . , , . , , - . , - , - .

(- ) - . , - - ( 1,56-1,72 ), - . 1,4-1,6 , - . ( 2-3,5 ) , - .

-. , - ; , , , - - .

, - - ,

-, - - [1,14].

, - 6 , . , - 63,5 0,7 ( () + 0,5 6,6 , : 4,2 ). - 8.2 0,5 ( 4,0 10,7 , p

55

CMYK 55

3 2012 -

, 2,4 , ( ) 1,26 .

, , - , , - . , 212 151 , - 10 390 10 460 ; 3100 3470 ; 35 37 .

, T - , - , : , , , - - ; , , - . , - 4 6- -.

, , , - ; - . , -

. , - ( ) . - , - [4]. , - -, , [5-7], - [19].

. - -, - , -, , , , - . , . - - - .

- - [20]. , , - , ..

.

1. .. . .: . 2003. 468.2. - . -

..:2004. 32 . 3. .., .., .. . .:. 2005. 206 .4. .. , //. . .

1995. 9. . 230234.5. .. - ?//.

1989. N. 5. . 94-96.6. .. . .:. 1990. 152 c. 7. .., .. .. : ..: URSS. 2010. 680 c.8. .., .., .., . . //

. 2002. 3. .34-35.9. .., . . // . - .

: - . . 29 2003. . 22-26.10. Lawrence H. S., Borkowsky W. Transfer Factor current, status and future prospects// Biotherapy.1996 Vol.9. P. 1-3.11. .. , . // . . . : -

- . . 29 2003. . 27-28.12. .. : ( .

. . .. ). . 2001. 73 .13. Warner, H. R., Ingram, D., Miller, R. A., Nadon, N. L., and Richardson, A.G. Program for testing biological interventions to promote healthy aging. //

Mech. Ageing Dev. 2000. Vol.115. P. 199-208.14. .. : // . 2000. .4. .33-40.15. .., .. : // .

. ..:2010. . 43. . 52-76.16. .. /. , . " ". . 1984.

180 .17. .., .. : .

2007614122 26 2007 . 18. .,, .., .. .

" ". ..:. 2003. 27 .19. .., .., .., ..

( ).. . 2400239 27 .2010 .20. .., .., .. ( ). . . 2404784 27

2010 .

56

CMYK 56

3 2012

. - - , . - , , , - . . 6- 4 . .

: Abstract. The bioadditive "Transfer-Factor" (TF) demonstrated the positive action on immune factors in old animals,

and shown the complex geroprotective action in experiments on mice. It positively effects on the physical condition, animal power, metabolism, as well as on biochemical mechanisms of ageing. It also restored the cellular potential of the tissue growing in old animal. Person using TF reduced age biomarkers and lowered the biological age on 4 year. The bioadditive TF is perspective as geroprotective agent.

Keywords

. E-mail: krutkovn@mail.ru . E-mail: mag70@yandex.ru . E-mail: dontsovvi@mail.ru. . E-mail: ptica1965@yandex.ru.

57

CMYK 57

3 2012

615.81

1 ..: ;1Niu Xin.: , ;2 ..: , ...;3 ..: , ..., .1 , , 2 --, ., 3 , .,

. C () - () 4 8%% 15 18 %% 60 . - - . - [1-3].

, , , -, . , - -, , - , -, [4-7]. , - (), (-) , .

- , - , 10% - . - . [1, 8, 9]. , . ?, [8], . - .

- ()

. - (.. , 1979; .. , .. -, 1994; .. , .. , 1998) - (1959). [10, 11] - -, .

- - , - . , acupuncture 14.04.2012 PubMed 17663 , acupuncture pain - 4762, cupuncture osteoarthritis 358, cupuncture rheumatoid arthritis 159, acupuncture fibromyalgia - 112, acupuncture thyroid - 55, acupuncture thyroidism 21, acupuncture hyperthyroidism - 14, acupuncture hypothyroidism 5. acupuncture subclinical hypothyroidism - [12] .

- - .

. - 42 35 65 , - -- , , . - [13]. 4 - .

27 . - 10 - 14 , - . - , , - - . , BD-SZ (, , ) [14].

58

CMYK 58

3 2012. - - ( ). , . - -, .

15 , .

- - .

%% - 0 10 . ( : 0.4 4 /) T4 ( : 11.5 23.2 /) - , . - SF36 - .

. - , -. . 1.

1. -. (n , N - ).

, N=27

n (n/N100)/ , N=15

n (n/N100)/

1 (, ) 21(78)/5,2 2(7)/1,5 12(80)/4,1 9(60)/2,9

2 , 20(74)/6,7 6(22)/3,2 12(80)/6,0 4(27)/2,8

3 , , 20(74)/6,7 3(11)/1,0 11(73)/6,2 4(27)/2,3

4 , , 15(55)/4,9 3(11)/2,4 10(67)/4,5 5(33)/2,5

5 , 14(52)/3,7 5(18)/2,5 8(53)/4,0 7(47)/3,2

6 , , 13(48)/3,9 6(22)/2,3 7(47)/3,4 3(20)/1,9

7 , 12(44)/5,0 0(0)/0 7(47)/4,5 2(13)/1,2

8 , 6(22)/3,1 2(7)/1,5 3(20)/3,5 1(7)/1,0

9 5(18)2,9 0(0)/0 1(7)/2,0 0(0)/0

: , - (%%) , / - .

- , , , - . , - , - [13]. - [15]. - . , - / [16, 17].

, - . - (1 . 1) - .

- . 2.

, - (0,4 4,0 /). . - , , - 2

. - (. 3).

2. .

Groups

1 (/) 2 (/) 3 (/)

(n=27) 8,9 2,3 4,2 1,1* 2,30,3* (n=15) 9,3 3,5 2,0 1,9* 7,5 3,4

. : 1 -, 2 , 3 . * - (0,05), ** - (0,01) - .

- SF36, , . 18,4 . .

[12] , 27 , - , - . - , . -

59

CMYK 59

3 2012

, - .

- . , - . - - [18, 19].

, , - [20]. , , , .

. - - , -.

3. SF36

Scale SF36AP group, N=27 LRT group, N=15

before after before afterPF 53,2 2,1 68,0 2,5 54,52,5 61,32,5RP 39,5 1,5 70,1 3,2 42,03,3 50,02,8RE 47,7 1,5 75,3 2,7 50,72,9 52,22,1SF 45,8 1,7 78,5 2,4 43,02,5 47,42,8BP 46,7 1,9 71,9 3,2 49,62,6 53,22,4VT 71,1 2,6 78,7 3,1 67,02,7 70,01,8MH 75,0 1,2 78,5 2,8 76,82,4 78,31,4GH 75,1 2,0 80,0 2,9 64,62,8 62,43,0

56,7 1,8 75,1 2,6* 56,02,9 55,62,4

: PF - Physical Functioning, RP Role Physical Functioning, RE Role-Emotional, Social Functioning SF, BP Bodily Pain, VT Vitality, MH Mental Health, GH General Health. * - (0,05) .

:

1. .. : // - . 2010, . 6, 2: 3-10.

2. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008 Feb;29(1):76-131.3. Hamilton TE, Davis S, Onstad L, Kopecky KJ. Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid

disease; implications for the diagnosis of subclinical hypothyroidism. J Clin Endocrinol Metab 2008;93:122430.4.Grosse S.D, Van Vliet G. Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level? // Arch.

Dis. Child. 2011, 96(4):374-379.5. Hercbergs A.H, Ashur-Fabian O., Garfield D. Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology // Curr. Opin. Endocrinol.

Diabetes Obes. 2010, 17(5):432-436.6. Duntas L.H., Biondi B. New insights into subclinical hypothyroidism and cardiovascular risk // Semin. Thromb. Hemost. 2011, 37(1):27-34.7. Atis G., Dalkilinc A., Altuntas Y., et. al. Sexual dysfunction in women with clinical hypothyroidism and subclinical hypothyroidism // J. Sex. Med. 2010,

7(7):2583-2590.8. Laryea E.A. Subclinical hypothyroidism. To treat or not to treat // Canad. Family Phys. Med. 1993.- V. 39:1997-8, 2001-3. 9. Todd C.H. Management of thyroid disorders in primary care: challenges and controversies. Postgrad Med J. 2009 Dec;85(1010):655-9.10. .. - // . 2003. 3(6). . 58-60.11. .. // 4 (11) 2004.

. 24-27.12. .., .., .. "-

" // , . -2011.- 5. - .29-33.13. .. http://www.paininfo.ru/practitioner/neurology/fibromialgia/about/14. NIU Tingli, YANG Xuezhi, ZHU Qing Wen Clinical trial and assessment of a portable apparatus for auxiliary diagnosis and treatment based on four

TCM diagnostic methods // Journal of Beijing University of Traditional Chinese Medicine.- 2011.-Vol. 34 No. 4. -. 231-235.15. Bazzichi L, Rossi A, Zirafa C, et al. Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia? Rheumatol Int. 2012

Feb;32(2):335-41.16. Terry R, Perry R, Ernst E.An overview of systematic reviews of complementary and alternative medicine for fibromyalgia. Clin Rheumatol. 2012

Jan;31(1):55-66.17. Mist SD, Wright CL, Jones KD, Carson JW.Traditional Chinese medicine diagnoses in a sample of women with fibromyalgia. Acupunct Med. 2011

Dec;29(4):266-9.18. .. // . 2004, 1(8). . 7-18.19. .. : -

// 90- . . 2011. . 88-94.20. Nillni EA. Regulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputs. Front Neuroendocrinol.

2010 Apr;31(2):134-56.

. 27 . , , , ( ). - - , BD-SZ (). 15 . - -

60

CMYK 60

3 2012 . 8,9 4,2 /, - 2,3 /. 2,0 /, - . , . .

: , , , -, - , .

AbstractAn increased level of TSH and a normal range of thyroid hormones were diagnosed in27 patients suffering symptoms of

arthralgiaand myalgia, common symptoms of hypothyroidism.Main treatment methods include regular body acupuncture, auricular acupuncture, scalp acupuncture and wrist reflex

zone acupuncture. The method is chosen in accordance to the existing symptoms. Other methods include local acupuncture on non- acupoints, specifically insertion of needles into the skin protuberance of the thyroid gland, as well as Gua Sha Scraping technique on the cervical and thoracic spine paravertebral areas.

The comparison group consists of 15patients, each receiving levothyroxine therapy (LRT) in individually modified doses. All patients had nearly the same clinical manifestations. Results show significant positive clinical changes in the acupuncture group. The average level of TSH of the "acupuncture" group decreased from8.9to4,2mU/l, and decreased further down a month after the end of treatment to2,3mU/l.In the LRT group, TSH levels dropped to 2,0 mU/l over the course of a month, but returned to the initial blood levels within a month after the treatment.

Acupuncture significantly increases the quality of life of patients and treatment shows long term effect, while LRT shows positive short term results, but does not show long lasting effects. Thus acupuncture should be considered as an alternative to hormone replacement therapy in subclinical hypothyroidism.

Key words: subclinical hypothyroidism, fibromyalgia acupuncture, levothyroxine replacement therapy, Thyrotropin-Stimulating Hormone, health-related quality of life.

. E-mail: cami lu camilla.sin@live.ru . E-mail: vasilenko-a-m@mail.ru

-

615.837.3, 616.37-002, 612.15

1 ..: -;2 ..: , ..., ;2 ..: ;2 ..: , ..., ;2 ..: , ...,1 . N 35 , .2 , .

. () - - , . , () , , - -, , - . . -

- . - -, - [8].

- - .

- - -

61

CMYK 61

3 2012 () - .

. - 69 18-36 , . (22 ) , - (- , , , (0,06% , ) (, ), ). (47 -) . () - 18 .

- . - - . , 7 . - -01 ( , ),

- . . ( 1),

- - 26 % (

62

CMYK 62

3 2012 , [5].

- , - - () - 34% (0,05), () () 20 % (0,05) 29 % (0,05) .

, - - [6]. , - , , -. - , , , , [10], . , - - , , -, , . , , - , - .

, , - , - . - - 83% (0,05).

- - , - 21% (0,05) . , 0,01 - (NO) [4], . , - - (-) - , .

28 % - , 32% (0,05), - 27% (0,05) . , - 14% (0,05).

, - - - , NO, , , . , , - , , , - .

74 % (0,05)

. , - - - , - [7]. , - , - -.

. ( 2).

, , . , , , , , , [6]. , - .

, , , -, [1, 12]. . [3, 13] , 2+ . - , , - . , 2+- , , . [11]. () , , , , , .

-, , -, , (-, NO, . .) - (, II ..), [4]. - . . , , , - [11]. NO, , , . [4] , NO - . ,

63

CMYK 63

3 2012

NO 2+, -.

- , , , - . , - , , NO.

- Ca2+- NO-, - , , - - [1]. , - . , , , , . , , , . , , , -, , , .

, - - -

, , - , , . - , , , - [7]. , (-, - ) - , -. - , . , , . - , , .

. , - - - , , , - , . - - , , -.

-

-

- (, ,

)

(-, ,

)

. 2 -

:

1. .., .. - // . , 2010. .87-89.

2. .., .., .., .. - // . 2010. - 2. .30-35.

64

CMYK 64

3 20123. . . // .

2011. - 4. .72-76.4. .., .., .. . -

// . 2010. - 3. .10-14.5. . ., . ., . ., . .

// . 2010. - 1. - .61-67.6. . . -

// , . - 2009. - 5. .9-11.7. .., .., .. .

// . 2010. - 3. .34-38.8. ..

: . . ... ., 2010. 24 .9. .. // . 2010, 5. .15-20.10. .., .., .. //

. 2010. - 1. .77-79.Cho E.J., Park M.S., Kim S.S. et al. Vasorelaxing Activity of Ulmus davidiana Ethanol Extracts in Rats: Activation of Endothelial Nitric Oxide Synthase //

Korean J Physiol Pharmacol. 2011. - 15. .339-344.Fioramonti P., Onesti M.G., Fino P. et al. Extracorporeal shockwavetherapy for the treatment of venous ulcers in the lower limbs // Ann Ital Chir. 2012.

- 83. .41-44.Virdis A., Taddei S. How to evaluate microvascular organ damage in hypertension: assessment of endothelial function //High Blood Press Cardiovasc

Prev. 2011. - 18. .163-167.

. - , , , - , - . , - , , , , . , , - .

: , - , .Abstract. In this paper the positions of the pathogenetic role of microcirculatory disturbances seen in the development of

chronic generalized periodontitis and justified the choice of method of shock-wave therapy, based on the mechanism of ac-tion of which is increased tissue blood flow and neoangiogenesis, stimulation of metabolic processes, reducing the severity of fibro-sclerotic changes, anti-inflammatory and antibacterial properties . It is shown that the exchange rate of the shock-wave therapy has a marked change in performance of microcirculation, which appeared to maximize the nutritional blood flow due to increased endothelial and myogenic oscillation of periodontal microvasculature, resulting in depression of shunt blood flow, and, along with an increase in perfusion led to an increase in the bulk characteristics microhemodynamics. These changes indicate an increase in blood flow in the capillary bed of periodontitis, a significant modulation of microcirculatory processes, enhancing metabolic processes under the influence of shock-wave action.

Key words: microcirculation, shock wave therapy, chronic generalized periodontitis.

.. E-mail: mgmsu2002@mail.ru .. E-mail: drnag@mail.ru

3 2012

65, ,

CMYK 65

, ,

: .

612.39

..: , ..., - , .

, - . -, -.

, - , - 2, - .

, , - . , - , - .

:

- ;

- ;

- , , - ;

-;

() .

. -, . , , - , - , . , , , , , . , - , , , , , - - - .

.

, , -, , , , - - - 100 . , , 1900 . - 14,2%, 1977 . 48% - . : 1900 1970 . , , , , , , - , 50 56 , 510 575 .

, - . - , - . , - - , - , . - , , . -, , , , - , , . , . , . , 300 1 . , - , , -.

- , , - . , 20 - , - . . , 20 4 . , - , -

3 2012

66 , ,

CMYK 66

- 26,5 . . .

- (, , , , , ). 1977 2007 - - - 27,8% [4, 5, 6].

-

. 1955 . - -, - . 1984 . (). 1991 . - , - , - (food for specified health use - FOSHU). 2001 . , . .

, - - ( -, ), . , , - . - - . , : , - , - , .

: , , , , , -, , - . wellness , . - -. : - ; ; , ; (- , , , ) , , ; - , FOSHU.

, -

, -, , - , - -. - , , . , 1965 . -

41 , 124 ., 1980 . 57 238 . , , , - . 150 . 50 , - ( - - 99,9% ), 10-15 .

. - , . , . -, - . - , , , , , .

-. , . - . , -, , . - - . - - .

, , , RDA. , RDA - , - , - . RDA, .

- . , , - , - , - .

, - , - , , - . - - - : 2 , 1,5 , 1,5 . - 10 3,3 , .

- , . - , , , - , - .. . - , - , . , - , , , - , .

3 2012

67, ,

CMYK 67

-, - . , -, , : , ,

6

. -

:- -

- , ;

- , ( );

- - , , ( - , , - , , ).

, - , , - . - , , , . - , , , - (, , .), , .

, , - , - . - : , - .

- . , - , , , (, , ), - , - , - , .

, - , , . -, - : , - , , , , , ..

. - , , - , , , , .

, . , , , . , , , . - , -. - .

- ( ) . 1.

1. - 20002011

-

(2001 )

- 1560 (2000

2001 ), , %

- 1560 (2000

2001 ), , %

66 42,4 15,3

81 9,8 4,4

79 13,7 5,7

78 14,1 8,2

78 12,6 6,0

- 77 10,9 6,6

77 12,9 8,1

73 18,0 10,1

70 22,8 8,8

70 21,8 12,0

68 25,9 13,6

66 33,5 29,9

:

- .

Euromonitor 2010

. - - (Russia Now, 2010). 50 % - () (- Nielsen, 2009). , : - , (- Euromonitor, , 2010 ). Healhy Marketing Team, -: ? , 27 % 2008 1 , 2 22 % - . 2003 16 % .

3 2012

68 , ,

CMYK 68

HealthFocus 2008 , . - - (. 3).

3.

,

2008

29 % ,

24 %

, .

22 %

, 19 % , 17 % ,

10 %

8 %

. - - . - - , - . , . 2 HealthFocus 2010 . -. 1: (22 % ). - () - . - .

- . - . 2: . 3: - (16 %).

- . 4.

, - , - - . -. -

(, , , ) - .

4.

2004

2008

2010

29% 27% 16%

16% 22% 21%

12% 15% 10% 16% 10% 23% 10% 10% 10%

8% 6% 5%

3% 3% 1% 1% 2%

- - , , , - , , .

, - -, .

, - 2008 , . 5.

5. , (2008 )

58 % 58 % 57 % 55 % -

55 %

55 % 54 % 52 % 50 % (+50 %) ( )

48 %

47 % 40 % 36 % 35 % / 34 %

Euromonitor, 20122014 .

2. 10 DALY ( , - - ) 2002

-

-, %

DALY, %

1 35,5 1 16,52 23,0 2 16,33 17,1 3 13,44 12,9 4 12,35 12,5 5 8,5

6 1,9 6

7,0

7 9,0 7 4,68 1,2 8 2,29 1,2 9 1,1

10 0,9 10 1,0

: /

3 2012

69, ,

CMYK 69

:1. .. // .- 2007.- 7.- .64.2. .., .., .., .. . . : , 2010.3. .., ... . ., 2007.4. De Goede J, Verschuren WM, Boer JM, Kromhout D, Geleijnse JM. Gender-Specific Associations of Marine n-3 Fatty Acids and Fish Consumption

with 10-Year Incidence of Stroke. PLoS One. 2012;7(4) : e33866. 5. Ferra A, Del Mar Bibiloni M, Zapata ME, Pich J, Pons A, Tur JA. Body mass index, life-style, and healthy status in free living elderly people in menorca

island. J Nutr Health Aging. 2012;16(4) : 298-305.6. Heart Disease and Stroke Statistics2011 Update. A Report From the American Heart Association, 2012.7. Karppi J, Laukkanen JA, Mkikallio TH, Ronkainen K, Kurl S. Low @-carotene concentrations increase the risk of cardiovascular disease mortality

among Finnish men with risk factors. Nutr Metab Cardiovasc Dis. 2012 Apr 9. 8. Loreflt B, Wilhelmsson S. A Multifaceted Intervention Model Can Give a Lasting Improvement of Older peoples' Nutritional Status. J Nutr Health

Aging. 2012;16 (4) : 378-82.9. Moreau D, Salon C, Munier-Jolain N. How to hierarchize the main physiological processes responsible for phenotypic differences in large-scale

screening studies? Plant Signal Behav. 2012 Mar 1; 7 (3). 10. Murakami I, Hosono H, Suzuki S, Kurihara J, Itagaki F, Watanabe M. Enhancement or Suppression of ACE Inhibitory Activity by a Mixture of Tea and

Foods for Specified Health Uses (FOSHU) That Are Marketed as "Support for Normal Blood Pressure". ISRN Pharm.;2011:712196.11. Ogawa H. [The third function (regulation of physiological function) of food for prevention of lifestyle-related diseases - lose linkage to clinical ex-